What is Kiniksa Pharmaceuticals Ltd?
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 7.57B, and a P/E ratio of 73.0x.
A short list of Drug Manufacturers - Specialty & Generic names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 524,874 shares $1.2M | 0 |
| 9-12months | 11123,823 shares $5.2M | 0 |